Tekla Life Sciences Investors
USD20.12
+0.36 (+1.82%)
CEO
Daniel R. Omstead
IPO Date
1992-05-01
Sector
Financial Services
Industry
Asset Management
Exchange
NYSE
Country
US
Open
$19.95
Prev. Close
$19.76
Day Low
$19.85
Day High
$20.13
52W Low
$12.72
52W High
$20.13
Market Cap
$0.61B
Volume
0.09M
| 5.0 |
| 30 Sept 2023 | FY | 46.4% | 56.8% | 5.6% | 5.6% | 0.00 | 0.00 | 15.8 |
| 30 Sept 2022 | FY | 82.6% | -328.3% | -26.3% | -25.2% | 0.03 | 0.12 | -3.4 |
| 30 Sept 2021 | FY | 86.5% | 143.3% | 12.3% | 12.1% | 0.00 | 0.01 | 7.8 |
| 30 Sept 2020 | FY | 86.7% | 314.9% | 25.4% | 25.4% | 0.00 | 0.13 | 3.4 |
| 30 Sept 2019 | FY | 100.0% | -2887.8% | -18.4% | -18.2% | 0.00 | 1.80 | -5.0 |
| 30 Sept 2018 | FY | 100.0% | 1443.4% | 6.0% | 6.0% | 0.00 | 4.76 | 15.9 |
| 30 Sept 2017 | FY | 93.4% | 98.2% | 14.7% | 14.6% | 0.00 | 0.48 | 6.7 |
| 30 Sept 2016 | FY | 21.3% | -189.3% | -2.9% | -2.9% | 0.00 | 7.56 | -18.7 |
| -1.9 |
| 30 Sept 2024 | Q4 | 100.0% | 1830.0% | 7.6% | 7.6% | 0.00 | 0.32 | 3.1 |
| 31 Mar 2024 | Q2 | 100.0% | 2433.4% | 11.4% | 11.4% | 0.00 | 0.20 | 1.8 |
| 30 Sept 2023 | Q4 | 91.2% | -38.7% | -2.8% | -2.8% | 0.00 | 0.00 | -7.3 |
| 31 Mar 2023 | Q2 | 100.0% | 1752.1% | 8.0% | 7.8% | 0.00 | 0.00 | 2.7 |
| 30 Sept 2022 | Q4 | 87.8% | -130.5% | -7.1% | -6.8% | 0.00 | 0.12 | -3.1 |
| 31 Mar 2022 | Q2 | 71.4% | -750.1% | -17.5% | -17.0% | 0.00 | 0.96 | -1.4 |
| 30 Sept 2021 | Q4 | 80.6% | 206.4% | 6.3% | 6.2% | 0.00 | 0.01 | 3.9 |
| 31 Mar 2021 | Q2 | 89.8% | 108.7% | 6.3% | 6.3% | 0.00 | 0.13 | 3.8 |